Carbapenems [DG:DG01458] are a class of beta-lactam antibiotics often used as the last resort treatment for severe bacterial infections. Thus, the appearance of carbapenem resistance caused by acquisition of carbapenem-hydrolyzing beta-lactamases (carbapenemases), especially among Enterobacteriaceae, Pseudomonas and Acinetobacter, is considered as a global health threat.
Category
Bacterial infectious disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
21 Symptoms, signs or clinical findings, not elsewhere classified
General symptoms, signs or clinical findings
Finding of microorganism resistant to antimicrobial drugs
MG50 Finding of gram negative bacteria resistant to antimicrobial drugs
H01422 Carbapenem-resistant bacterial infection
Genome-based classification of infectious diseases [BR:br08401]
Bacterial infections
Infections caused by bacteria
H01422 Carbapenem-resistant bacterial infection
Infectious diseases by law in Japan [br08406.html]
H01422
